Controlling dangerous inflammation during open heart surgery

April 18, 2017

From the April 2017 issue of HealthCare Business News magazine

For the large number of patients who undergo major cardiac surgery in the U.S. and around the world each year, better therapies are needed to lower the risk of serious postoperative complications. These various strategies, that use different methods to counter inflammation, are likely to act in synergy. This could pave the way for safer and more predictable clinical outcomes in complex cardiac surgery that is anything but routine.

About the author: Dr. Phillip P. Chan, M.D., Ph.D., is chief executive officer and president of CytoSorbents Corporation.

Back to HCB News

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!